Page last updated: 2024-10-29

ketoconazole and Blood Diseases

ketoconazole has been researched along with Blood Diseases in 2 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research Excerpts

ExcerptRelevanceReference
"Zygomycosis is an opportunistic fungal infection that is increasingly reported in hematological patients."2.42Improved outcome of zygomycosis in patients with hematological diseases? ( Anagnostopolous, I; Gleissner, B; Schilling, A; Siehl, I; Thiel, E, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gleissner, B1
Schilling, A1
Anagnostopolous, I1
Siehl, I1
Thiel, E1
Berenguer Berenguer, J1

Reviews

2 reviews available for ketoconazole and Blood Diseases

ArticleYear
Improved outcome of zygomycosis in patients with hematological diseases?
    Leukemia & lymphoma, 2004, Volume: 45, Issue:7

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspe

2004
[Commonly used antifungal agents in the treatment of systemic mycoses].
    Revista clinica espanola, 1995, Volume: 195 Suppl 3

    Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Top

1995